In a high-fat diet (HFD)-induced mouse model of NAFLD, inhibition of TNF-receptor-1 significantly reduced liver steatosis, improved insulin resistance, decreased liver injury, and decreased liver fibrosis, suggesting TNFR1 as a promising approach for NAFLD treatment [57]. This evidence concerns the gene TNFRSF1A and metabolic dysfunction-associated steatotic liver disease.